Clinical significance of <scp>PNO1</scp> as a novel biomarker and therapeutic target of hepatocellular carcinoma

Sanjit K. Roy(The University of Kansas Cancer Center), Rohit Srivastava(The University of Texas Health Science Center at Tyler)

Journal of Cellular and Molecular Medicine

May 1, 2024

10.1111/jcmm.18295

Cited by 4

Related Papers

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

|Journal of Molecular Signaling|2010|374

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

|PLoS ONE|2011|301

Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

|International Journal of Oncology|2007|235

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

|Journal of Molecular Signaling|2010|221

Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer

|Oncotarget|2014|192